Weld Capital Management’s NeoGenomics NEO Stock Holding History

Weld Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,630	Closed	-$895K	–	469
2020 Q4	$895K	Buy	16,630 +11,031	+197%	+$498K	0.35%	79
2020 Q3	$207K	Buy	+5,599	New	+$208K	0.08%	384
2019 Q3	–	Sell	-26,546	Closed	-$582K	–	924
2019 Q2	$582K	Sell	26,546 -17,782	-40%	-$390K	0.11%	340
2019 Q1	$907K	Buy	+44,328	New	+$770K	0.17%	231

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Weld Capital Management's NEO Position: Q1 2021 in Review

Weld Capital Management sold out of NeoGenomics (NEO) in Q1 2021, closing a stake of 16,630 shares — an estimated $895K sold.

Weld Capital Management first reported a position in NEO in Q1 2019 and held it in 4 quarters. The position peaked at $907K in Q1 2019. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

Weld Capital Management reported no remaining NeoGenomics position as of Q1 2021 after selling out during the quarter.
Weld Capital Management sold 16,630 NeoGenomics shares in Q1 2021, an estimated $895K.
Weld Capital Management first reported a position in NeoGenomics in Q1 2019 and held it in 4 quarters.
Weld Capital Management's NeoGenomics position peaked at $907K in Q1 2019.
332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.